MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suko, J.
Right arrow Articles by Drobny, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suko, J.
Right arrow Articles by Drobny, H.

Vol. 59, Issue 3, 543-556, March 2001

Short- and Long-Term Functional Alterations of the Skeletal Muscle Calcium Release Channel (Ryanodine Receptor) by Suramin: Apparent Dissociation of Single Channel Current Recording and [3H]Ryanodine Binding

Josef Suko, Gertrude Hellmann, and Helmut Drobny

Institute of Pharmacology, University of Vienna, Vienna, Austria

The present study demonstrates the following characteristic suramin actions on the purified skeletal muscle calcium release channel in single-channel current recordings and [3H]ryanodine binding to HSR: 1) Suramin (0.3-0.9 mM) induced a concentration-dependent increase in the open probability (Po congruent  0.9) at 20 to 100 µM Ca2+ and an almost fully open channel at 1 mM Ca2+ (Po = 0.95) with a marked shift to longer open states (tau o3/tau o4). Suramin increased the apparent calcium affinity to the activating high-affinity calcium binding sites and reduced the apparent magnesium affinity to the inhibitory low affinity Ca2+/Mg2+ binding sites. 2) Channel activation by suramin and sulfhydryl oxidation was additive. 3) Suramin (0.9 mM) reversed the Ca-calmodulin-induced channel inhibition at 0.1 or 1 to 5 µM Ca-calmodulin. 4) The open probability of the suramin activated channel was almost completely inhibited by 10 mM Mg2+ or Ca2+ on short suramin exposure. Prolonged suramin exposure (30-60 min) resulted in a time-dependent, slow increase in Po, with long open states of low frequency in the presence of 10 to 20 mM Mg2+ or Ca2+. 5) Magnesium induced inhibition of Po (IC50 = 0.38 mM) and equilibrium [3H]ryanodine binding (IC50 = 0.30 mM) agreed well in control channels, but were dissociated in the presence of 0.9 to 1.0 mM suramin (IC50 = 0.82 mM versus 83 mM). [3H]ryanodine binding seemed to monitor predominantly the long-term alteration in channel function. 6) The multiple effects of suramin on channel function suggest an allosteric mechanism and no direct effects on binding of endogenous ligands involved in channel gating.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Biophys. JHome page
E. R. O'Neill, M. M. Sakowska, and D. R. Laver
Regulation of the Calcium Release Channel from Skeletal Muscle by Suramin and the Disulfonated Stilbene Derivatives DIDS, DBDS, and DNDS
Biophys. J., March 1, 2003; 84(3): 1674 - 1689.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. V. L. Papineni, K. M. S. O'Connell, H. Zhang, R. T. Dirksen, and S. L. Hamilton
Suramin Interacts with the Calmodulin Binding Site on the Ryanodine Receptor, RYR1
J. Biol. Chem., December 13, 2002; 277(51): 49167 - 49174.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics